EDITORIALS

Cannabis for Refractory Chemotherapy-Induced Nausea and Vomiting

  • Zimmermann, Camilla MD, PhD2,,

  • 1

    Department of Supportive Care, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada

  • 2

    Division of Palliative Medicine and Division of Medical Oncology, Department of Medicine, University of Toronto, Toronto, Canada
Camilla Zimmermann, MD, PhD; e-mail: [email protected].
Journal of Clinical Oncology 42(34):p 4008-4011, December 1, 2024. | DOI: 10.1200/JCO.24.00438

Corresponding Article

Oral Cannabis Extract for Secondary Prevention of Chemotherapy-Induced Nausea and Vomiting: Final Results of a Randomized, Placebo-Controlled, Phase II/III Trial

  • Grimison, Peter PhD, MPH, MBBS, BSc, FRACP2,,
  • Mersiades, Antony MBBS3,
  • Kirby, Adrienne MSc, BSc (Hons I)2
  • Tognela, Annette MBBS4
  • Olver, Ian MD, PhD, AM5,
  • Morton, Rachael L. PhD, MScMed(Clin Epi)(Hons)2
  • Haber, Paul PhD, MBBS, BMedSci, FAChAM6,
  • Walsh, Anna BPharmForenSc2
  • Lee, Yvonne PhD2
  • Abdi, Ehtesham MBBS (Adel), AFRACMA, FRACP, FACP7
  • Della-Fiorentina, Stephen OAM, MBBS (Hons), FRACP8
  • Aghmesheh, Morteza MD, PhD9
  • Fox, Peter MBBS10
  • Briscoe, Karen MBBS11,
  • Sanmugarajah, Jasotha MBBS12,
  • Marx, Gavin MBBS13
  • Kichenadasse, Ganessan MBBS14
  • Wheeler, Helen MBBS15
  • Chan, Matthew MBBS16
  • Shannon, Jenny MBBS17
  • Gedye, Craig MBBS18,
  • Begbie, Stephen MBBS19,
  • Simes, R. John MD, PhD2,
  • Stockler, Martin R. MBBS2,
Journal of Clinical Oncology 42(34):p 4040-4050, December 1, 2024. | DOI: 10.1200/JCO.23.01836
Copyright © 2024 by American Society of Clinical Oncology
View full text|Download PDF